UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000046626 |
|---|---|
| Receipt number | R000053156 |
| Scientific Title | Trial of the effect of taking collagen peptide on muscle and joint disorders in athletes |
| Date of disclosure of the study information | 2022/01/17 |
| Last modified on | 2022/11/01 11:44:51 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Trial of the effect of taking collagen peptide on muscle and joint disorders in athletes
Acronym
Trial of the effect of taking collagen peptide on muscle and joint disorders in athletes
Scientific Title
Trial of the effect of taking collagen peptide on muscle and joint disorders in athletes
Scientific Title:Acronym
Trial of the effect of taking collagen peptide on muscle and joint disorders in athletes
Region
| Japan |
Condition
Condition
None
Classification by specialty
| Not applicable |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
Trial of the effect of taking collagen peptide on muscle and joint disorders
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Confirmatory
Trial characteristics_2
Developmental phase
Not applicable
Assessment
Primary outcomes
Questionnaire, length of the front bent
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Parallel
Randomization
Randomized
Randomization unit
Individual
Blinding
Double blind -all involved are blinded
Control
Placebo
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
2
Purpose of intervention
Prevention
Type of intervention
| Food |
Interventions/Control_1
Ingestion of test food (3 months)
Interventions/Control_2
Ingestion of placebo food (3 months)
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| 25 | years-old | >= |
Gender
Male and Female
Key inclusion criteria
Athletes belonging to University Athletic Club who are healthy and not suffered from a chronic malady.
Individuals whose written informed consent has been obtained.
Key exclusion criteria
Individuals who have possibility of allergy symptoms onset by the test food and who cause allergic symptoms in foods and medicines.
Individuals who have a habit to ingest collagen peptides on a daily basis.
Target sample size
120
Research contact person
Name of lead principal investigator
| 1st name | Toshihiro |
| Middle name | |
| Last name | Kawama |
Organization
Morinaga & CO., LTD.
Division name
R & D institute
Zip code
230-8514
Address
2-1-1, shimosueyoshi, tsurumi-ku, yokohama, kanagawa, 230-8504 Japan
TEL
045-571-2982
t-kawama-jb@morinaga.co.jp
Public contact
Name of contact person
| 1st name | Ryo |
| Middle name | |
| Last name | Tanaka |
Organization
Morinaga & CO., LTD.
Division name
R & D institute
Zip code
230-8514
Address
2-1-1, shimosueyoshi, tsurumi-ku, yokohama, kanagawa, 230-8504 Japan
TEL
045-571-2982
Homepage URL
r-tanaka-ba@morinaga.co.jp
Sponsor or person
Institute
Morinaga & CO., LTD.
Institute
Department
Personal name
Funding Source
Organization
Morinaga & CO., LTD.
Organization
Division
Category of Funding Organization
Profit organization
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Non-Profit Organization MINS Institutional Review Board
Address
5-20-9-401,Mita,Minato-ku,Tokyo,Japan
Tel
03-6416-1868
npo-mins@j-irb.com
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2022 | Year | 01 | Month | 17 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2022 | Year | 01 | Month | 12 | Day |
Date of IRB
| 2022 | Year | 01 | Month | 12 | Day |
Anticipated trial start date
| 2022 | Year | 02 | Month | 07 | Day |
Last follow-up date
| 2022 | Year | 09 | Month | 30 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2022 | Year | 01 | Month | 13 | Day |
Last modified on
| 2022 | Year | 11 | Month | 01 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053156
